Part Details | THEOPHYLLINE EXTENDED-RELEASE CAPSULES
6505-01-164-8737
Alternate Parts: SLOBID 300 GYROCAPS, SLO-BID 300 GYROCAPS, SLOBID 300, SLO-BID 300, NDC00075030062, NDC00075-0300-62, NDC00603595221, NDC00603-5952-21, NDC00258362501, NDC00258-3625-01, NDC00904784960, NDC00904-7849-60, 6505-01-164-8737, 01-164-8737, 6505011648737, 011648737
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | OCT 21, 1983 | 01-164-8737 | 42774 ( THEOPHYLLINE EXTENDED-RELEASE CAPSULES ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-164-8737
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| SLO-BID 300 GYROCAPS | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
| SLO-BID 300 | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
| NDC00075-0300-62 | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
| NDC00603-5952-21 | 0ET99 | GENERICS BIDCO I, LLCDBA PAR PHARMACEUTICAL |
| NDC00258-3625-01 | 6X308 | INWOOD LABORATORIES INC |
| NDC00904-7849-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC |
Technical Data | NSN 6505-01-164-8737
| Characteristic | Specifications |
|---|---|
| CAPSULE TYPE | |
| CAPSULE CONTENT FORM | |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB300.000 MILLIGRAMS THEOPHYLLINE |
| PRIMARY CONTAINER TYPE | STRIP |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| FEATURES PROVIDED | UNIT DOSE |
| THERAPEUTIC EQUIVALENT | SLO-BID GYROCAP BY RORER PHARM |
| SPECIAL FEATURES | ANHYDROUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG |